Research on rare cancers is ongoing, with efforts focused on understanding the underlying biology, developing new treatments, and improving diagnostic methods. Collaborative initiatives like the Rare Tumor Initiative by the National Cancer Institute aim to accelerate research by aggregating data and fostering international cooperation.
